We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Deutsche (DB) Might File Lawsuit Against Two Ex-Madoff Funds
Read MoreHide Full Article
Deutsche Bank (DB - Free Report) has been given green signal by a U.S. judge to sue two offshore funds for backing out of a deal under which they were supposed to sell $1.6 billion of claims in the bankruptcy of fraud Bernard Madoff's firm. The news was reported by Reuters.
Kingate Global Fund and Kingate Euro Fund are the two funds that channeled client money to Madoff before his Ponzi scheme collapsed in 2008. The article said, Deutsche Bank has accused them of having "sellers' remorse" as they agreed to sell the claims at 66 cents on the dollar in 2011, and later witnessed their value increase significantly.
U.S. District Judge Edgardo Ramos in Manhattan refused to dismiss the lawsuit stating that the agreement was "firm, irrevocable and binding". He also said that Deutsche Bank can pursue a claim that the Kingate funds acted in bad faith by filing for protection under bankruptcy in September 2019 to escape any legal encounters.
Brief Background
Madoff’s hedge fund was one of the largest financial frauds that cost its clients about $65 billion in a Ponzi scheme. It came to light in December 2008.
The fraudster collected money from clients under the company name of Bernard L. Madoff Investment Securities LLC with no intentions of investing it, per the scheme he had informed them of. Madoff instead used the money collected from new investors to return principal and fictitious profits to older ones.
Late last year, U.S. Department of Justice announced that The Madoff Victim Fund will distribute payments to more than 30,000 people globally who were wronged out of their investments between 1970 and 2000.
Our Take
Deutsche Bank's cost-control moves and its several strategic initiatives are expected to support financials in the quarters ahead. Also, efforts to improve operating efficiency are likely to support profitability.
Shares of Deutsche Bank have gained 42.9% over the past six months compared with the industry’s growth of 46.4%.
UBS Group AG (UBS - Free Report) has witnessed upward earnings estimate revisions for 2021 in the past 60 days. Moreover, this Zacks Rank #2 stock has gained 38.9% in six months’ time.
Bank Of Montreal’s (BMO - Free Report) current fiscal-year earnings estimates have moved north in 60 days’ time. Further, the company’s shares have appreciated 45% over the past six months. At present, it flaunts a Zacks Rank of 1.
Barclays PLC (BCS - Free Report) has witnessed upward earnings estimate revision for the ongoing year in the past 60 days. This Zacks #2 Ranked stock has gained 102.2% in the past six months.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Deutsche (DB) Might File Lawsuit Against Two Ex-Madoff Funds
Deutsche Bank (DB - Free Report) has been given green signal by a U.S. judge to sue two offshore funds for backing out of a deal under which they were supposed to sell $1.6 billion of claims in the bankruptcy of fraud Bernard Madoff's firm. The news was reported by Reuters.
Kingate Global Fund and Kingate Euro Fund are the two funds that channeled client money to Madoff before his Ponzi scheme collapsed in 2008. The article said, Deutsche Bank has accused them of having "sellers' remorse" as they agreed to sell the claims at 66 cents on the dollar in 2011, and later witnessed their value increase significantly.
U.S. District Judge Edgardo Ramos in Manhattan refused to dismiss the lawsuit stating that the agreement was "firm, irrevocable and binding". He also said that Deutsche Bank can pursue a claim that the Kingate funds acted in bad faith by filing for protection under bankruptcy in September 2019 to escape any legal encounters.
Brief Background
Madoff’s hedge fund was one of the largest financial frauds that cost its clients about $65 billion in a Ponzi scheme. It came to light in December 2008.
The fraudster collected money from clients under the company name of Bernard L. Madoff Investment Securities LLC with no intentions of investing it, per the scheme he had informed them of. Madoff instead used the money collected from new investors to return principal and fictitious profits to older ones.
Late last year, U.S. Department of Justice announced that The Madoff Victim Fund will distribute payments to more than 30,000 people globally who were wronged out of their investments between 1970 and 2000.
Our Take
Deutsche Bank's cost-control moves and its several strategic initiatives are expected to support financials in the quarters ahead. Also, efforts to improve operating efficiency are likely to support profitability.
Shares of Deutsche Bank have gained 42.9% over the past six months compared with the industry’s growth of 46.4%.
Currently, Deutsche Bank carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Other Stocks to Consider
UBS Group AG (UBS - Free Report) has witnessed upward earnings estimate revisions for 2021 in the past 60 days. Moreover, this Zacks Rank #2 stock has gained 38.9% in six months’ time.
Bank Of Montreal’s (BMO - Free Report) current fiscal-year earnings estimates have moved north in 60 days’ time. Further, the company’s shares have appreciated 45% over the past six months. At present, it flaunts a Zacks Rank of 1.
Barclays PLC (BCS - Free Report) has witnessed upward earnings estimate revision for the ongoing year in the past 60 days. This Zacks #2 Ranked stock has gained 102.2% in the past six months.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>